BeyondSpring

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$1.37
Previous Close
$1.31
Day Range
$1.37-$1.37
52W Range
$0.98-$3.62
Market Cap
$52.8M
Shares Short
1M

Financials

See more
Revenue (12 Mos)
$1.8M
Revenue Growth (YoY)
14.3%
Gross Profit (12 Mos)
$1.3M
Diluted EPS
-$0.21

News

See more

Yahoo Finance • 26 days ago

BeyondSpring Files 2024 Annual Report on Form 10-K

Yahoo Finance • 3 months ago

SEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New Investors

Yahoo Finance • 3 months ago

BeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational Studies

Yahoo Finance • last year

BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors

About

CEO
Dr. Lan Huang Ph.D.
Address
100 Campus Drive, Florham Park, NJ, United States, 07932
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
40